| abstract |
The present invention provides a compound of formula (I). This compound is a selective inhibitor of the AGC kinase family and calmodulin-dependent kinases, such as, for example, MARK 1/2/3, PKD-1/2/3, PKN-1/2, CDK -9, CaMKII, ROCK-I / II, histone deacetylase phosphorylation inhibitors (HDAC) or other kinase inhibitors. In conclusion, the present invention also provides a pharmaceutical composition. |